冠状动脉钙化进展与冠状动脉斑块体积进展相关:基于定量半自动冠状动脉斑块分析的结果
连续纳入211例接受系列冠状动脉CT血管造影的患者,用半自动软件定量斑块体积。冠状动脉钙化进展与所有类型斑块体积的线性增加相关,无钙化进展者未见斑块进展;多变量分析中总斑块、非钙化斑块、纤维斑块和钙化斑块体积进展与钙化进展独立相关,而纤维脂肪斑块和低衰减斑块进展不相关。斑块进展无性别差异,他汀使用者总斑块和钙化斑块进展显著增加。
要点
- 冠状动脉钙化进展与总斑块、非钙化斑块、纤维斑块和钙化斑块体积进展独立相关。
- 纤维脂肪斑块和低衰减斑块进展与钙化进展无独立关联。
- 无钙化进展者未观察到斑块进展,斑块进展无性别差异。
核心结论
- 在临床实践环境中,除纤维脂肪斑块和低衰减斑块外,钙化进展与钙化和非钙化斑块体积增加显著相关;系列钙化测量可能有助于判断是否需要强化预防治疗。
研究设计与样本
- 连续纳入转诊至本诊所并接受系列冠状动脉CT血管造影检查的患者共211例(年龄61.3±12.7岁,男性75.4%),基线至随访扫描平均间隔3.3±1.7年,使用半自动斑块分析软件计算冠状动脉斑块体积。
关键影像表现/征象
- 钙化进展与所有类型冠状动脉斑块体积的显著线性增加相关。
- 无钙化进展的受试者中未观察到斑块进展。
- 斑块进展在性别间无差异。
- 他汀使用者中观察到总斑块和钙化斑块进展显著增加。
诊断标准与关键数值
- 多变量分析中,年化归一化总斑块体积进展(β=0.38;p<0.001)、非钙化斑块(β=0.35;p=0.001)、纤维斑块(β=0.56;p<0.001)和钙化斑块(β=0.63;p=0.001)进展与钙化进展独立相关。
- 纤维脂肪斑块(β=0.03;p=0.28)和低衰减斑块(β=0.11;p=0.1)进展与钙化进展无独立关联。
临床应用与阅片要点
- 系列冠状动脉钙化测量可能有助于判断是否需要强化预防治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to determine whether coronary artery calcium (CAC) progression was associated with coronary plaque progression on coronary computed tomographic angiography.
BACKGROUND: CAC progression and coronary plaque characteristics are associated with incident coronary heart disease. However, natural history of coronary atherosclerosis has not been well described to date, and the understanding of the association between CAC progression and coronary plaque subtypes such as noncalcified plaque progression remains unclear.
METHODS: Consecutive patients who were referred to our clinic for evaluation and had serial coronary computed tomography angiography scans performed were included in the study. Coronary artery plaque (total, fibrous, fibrous-fatty, low-attenuation, densely calcified) volumes were calculated using semiautomated plaque analysis software.
RESULTS: A total of 211 patients (61.3 ± 12.7 years of age, 75.4% men) were included in the analysis. The mean interval between baseline and follow-up scans was 3.3 ± 1.7 years. CAC progression was associated with a significant linear increase in all types of coronary plaque and no plaque progression was observed in subjects without CAC progression. In multivariate analysis, annualized and normalized total plaque (β = 0.38; p < 0.001), noncalcified plaque (β = 0.35; p = 0.001), fibrous plaque (β = 0.56; p < 0.001), and calcified plaque (β = 0.63; p = 0.001) volume progression, but not fibrous-fatty (β = 0.03; p = 0.28) or low-attenuation plaque (β = 0.11; p = 0.1) progression, were independently associated with CAC progression. Plaque progression did not differ between the sexes. A significantly increased total and calcified plaque progression was observed in statin users.
CONCLUSIONS: In a clinical practice setting, progression of CAC was significantly associated with an increase in both calcified and noncalcified plaque volume, except fibrous-fatty and low-attenuation plaque. Serial CAC measurements may be helpful in determining the need for intensification of preventive treatment.
引用
- Ceponiene I, Nakanishi R, Osawa K, et al. Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression: Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis. JACC Cardiovasc Imaging. 2017. PMID: 29055625. doi:10.1016/j.jcmg.2017.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。